Ross A. Soo

机构：National University Cancer Institute, Singapore, National University Hospital, National University Health System · ORCID：0000-0002-3053-3997

发表论文 686 篇 · 总被引 20030 次 · h-index 69

代表论文

• Osimertinib and Stereotactic Radiosurgery for Brain Metastases in EGFR-Mutated Lung Cancer: The STARLET Joint Analysis of OUTRUN and LUOSICNS Randomized Trials (2026 · Journal of Thoracic Oncology · 被引 6)
• PT2.12.03 Zongertinib in Patients With Previously Treated HER2-Mutant NSCLC and Brain Metastases at Baseline: Beamion LUNG-1 (2025 · Journal of Thoracic Oncology · 被引 5)
• A comparison of clinical guidelines, treatment characteristics and outcomes in small cell lung cancer between East Asia and Europe/North America (2025 · Frontiers in Oncology · 被引 4)
• PL02.15 Pivotal ARROS-1 Efficacy and Safety Data: Zidesamtinib in TKI Pre-treated Patients with Advanced/Metastatic ROS1+ NSCLC (2025 · Journal of Thoracic Oncology · 被引 4)
• A cost-effectiveness analysis model of actionable genomic alteration testing strategies incorporating different modalities and sizes of next-generation sequencing panels in non-small-cell lung cancer (2025 · Therapeutic Advances in Medical Oncology · 被引 1)
• High clinical actionability of a pan-cancer tissue-based combined DNA and RNA next generation sequencing assay in a diverse Asian population (2025 · npj Precision Oncology · 被引 1)